Study details
Enrolling now
IH, Brain Health, and T2D
Darren P Casey
NCT IDNCT07173543ClinicalTrials.gov data as of Apr 2026
Target enrollment
80
Study length
about 2.8 years
Ages
60–85
Locations
1 site in IA
About this study
Researchers are testing whether intermittent hypoxia can improve brain health in older adults with or without type 2 diabetes. The trial will last for 1012 days and involve approximately 80 participants who will be randomly assigned to either intermittent hypoxia or a sham treatment.
Based on ClinicalTrials.gov records.
What participants do
- 1.Intermittent Hypoxia 1 (IH1)
- 2.Intermittent Hypoxia 2 (IH2)
- 3.SHAM - normoxia
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low15%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Body systems
Endocrinology